Asymptomatic hemochromatosis subjects: genotypic and phenotypic profiles

被引:25
作者
Sham, RL
Raubertas, RF
Braggins, C
Cappuccio, J
Gallagher, M
Phatak, PD
机构
[1] Rochester Gen Hosp, Dept Med, Mary M Gooley Hemophilia Ctr Inc, Rochester, NY 14621 USA
[2] Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA
[3] Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
D O I
10.1182/blood.V96.12.3707.h8003707_3707_3711
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Screening for hereditary hemochromatosis (HHC) by means of transferrin saturation (TS) levels has been advocated and will identify many patients who are asymptomatic. The purposes of this study were (1) to determine HFE genotypes among asymptomatic HHC patients and correlate this profile with the degree of iron overload and (2) to evaluate the relationship between mobilized iron (mob Fe), age, serum ferritin (SF), and quantitative hepatic iron (QHI) in this population. One hundred twenty-three asymptomatic HHC patients were evaluated; ail had quantitative phlebotomy to determine mob Fe and genotyping for C282Y and H63D mutations. Liver biopsies with QHI determinations were performed an 72 of the 123 patients. Of the entire group, 60% were homozygous for C282Y, and 13% were compound heterozygotes (C282Y/H63D), Among asymptomatic patients, the prevalence of homozygous C282Y is lower compared with previous studies that include clinically affected patients, Of those patients with more than 4 g mob Fe, 77% were homozygous C282Y, Asymptomatic patients with lower iron burdens frequently had genotypes other than homozygous C282Y, There was no correlation between age and mob Fe in these patients; however, there was a correlation between mob Fe and both SF (r = 0.68) and QHI(r = 0.75). In conclusion, asymptomatic patients with moderate iron overload had a different genotypic profile than was seen in advanced iron overload. The significance of identifying patients with modest degrees of iron loading, who may not be homozygous for C282Y, must be addressed if routine TS screening is to be implemented. (C) 2000 by The American Society of Hematology.
引用
收藏
页码:3707 / 3711
页数:5
相关论文
共 31 条
[1]   SCREENING BLOOD-DONORS FOR HEREDITARY HEMOCHROMATOSIS - DECISION-ANALYSIS MODEL-BASED ON A 30-YEAR DATABASE [J].
ADAMS, PC ;
GREGOR, JC ;
KERTESZ, AE ;
VALBERG, LS .
GASTROENTEROLOGY, 1995, 109 (01) :177-188
[2]  
Adams PC, 1999, AM J GASTROENTEROL, V94, P1593
[3]  
ADAMS PC, 1991, AM J MED, V90, P445
[4]   HFE genotype in patients with hemochromatosis and other liver diseases [J].
Bacon, BR ;
Olynyk, JK ;
Brunt, EM ;
Britton, RS ;
Wolff, RK .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (12) :953-962
[5]   SCREENING FOR HEMOCHROMATOSIS [J].
BASSETT, ML ;
HALLIDAY, JW ;
BRYANT, S ;
DENT, O ;
POWELL, LW .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1988, 526 :274-289
[6]  
BASSETT ML, 1984, GASTROENTEROLOGY, V87, P628
[7]   VALUE OF HEPATIC IRON MEASUREMENTS IN EARLY HEMOCHROMATOSIS AND DETERMINATION OF THE CRITICAL IRON LEVEL ASSOCIATED WITH FIBROSIS [J].
BASSETT, ML ;
HALLIDAY, JW ;
POWELL, LW .
HEPATOLOGY, 1986, 6 (01) :24-29
[8]   HLA-H mutations in the Ashkenazi Jewish population [J].
Beutler, E ;
Gelbart, T .
BLOOD CELLS MOLECULES AND DISEASES, 1997, 23 (06) :95-98
[9]  
Beutler Ernest, 1996, Blood Cells Molecules and Diseases, V22, P187, DOI 10.1006/bcmd.1996.0027
[10]  
BORWEIN S, 1984, CAN MED ASSOC J, V131, P895